Showing results (201-210 of 227) with videos related to

Sort By:
Pageof 23
Stroke|March 1, 1996
Reactive glia express cytosolic phospholipase A2 after transient global forebrain ischemia in the ratJ A Clemens, D T Stephenson, E B Smalstig, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1989
Preclinical studies on quinelorane, a potent and highly selective D2-dopaminergic agonistM M Foreman, R W Fuller, M D Hynes, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|February 21, 2022
A randomized, open-label, multicenter study of switching to brolucizumab with or without a loading dose for patients with suboptimal anatomically controlled neovascular age-related macular degeneration-the FALCON studyF G Holz, Steffen Schmitz-Valckenberg, A Wolf, et al.
Radiology|February 26, 2003
Lung cancer screening with CT: Mayo Clinic experienceStephen J Swensen, James R Jett, Thomas E Hartman, et al.
Drug Design and Discovery|January 1, 1993
Progress in the medicinal chemistry of dopaminergic agentsJ M Schaus, E C Kornfeld, R D Titus, et al.
Journal of Food Protection|September 16, 2005
Development of immunoassay for detection of meat and bone meal in animal feedShin-Hee Kim, Tung-Shi Huang, Thomas A Seymour, et al.
Life Sciences|March 12, 1984
Stimulation of presynaptic dopamine autoreceptors by 4-(2-di-n-propylaminoethyl) indole (DPAI)J A Clemens, R W Fuller, L A Phebus, et al.
Metabolism: Clinical and Experimental|October 27, 1999
Octreotide (somatostatin analog) treatment reduces endothelial cell dysfunction in patients with diabetes mellitusA Clemens, M S Klevesath, M Hofmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 15, 2020
ORAI1 and ORAI2 modulate murine neutrophil calcium signaling, cellular activation, and host defenseDerayvia Grimes, Ryan Johnson, Madeline Pashos, et al.
Pageof 23